Health and Pharmaceuticals

The importance of care and innovation for human health has never been more widely recognized by society than it is today. The pharmaceutical industry has always played a significant role by investing in the development of new drugs to support people’s health and lives.

Health is essential in building healthy and productive societies, while ensuring that people can live longer and better should be a commitment shared by all. Companies, governments, the medical community, institutions and patient organizations all have a critical role to play in achieving health and well-being for the general population.

According to the World Health Organization, the most important healthcare challenges include access to better and more effective drugs, the need to invest in improving healthcare systems and to effectively tackle current and emerging healthcare problems. The COVID-19 outbreak has clearly demonstrated that we need global responses to global pandemics.

Now is the time for more comprehensive analysis, paying attention to and understanding the role of patients, the importance of public-private partnerships, the importance of transparency in research and development (R&D) regarding the price of drugs, access to those drugs and therapy adherence, the importance of technology and the role of companies to significantly improve perception of the industry, while building a better business environment.
The Healthcare Sector and the Future of Pharmaceutical Companies

Contact an LLYC expert.

Senior Director Healthcare Americas
Javier Marín
+52 55525 71084
Partner and Managing Director Barcelona
María Cura
+34 932 17 22 17
Partner and Managing Director Northern Region
Javier Rosado
+507 206 5200
Partner and Chief Operating Officer Latin America
Juan Carlos Gozzer
+55 11 3060 3390
Partner and Chief Talent Officer
Luis Miguel Peña
+51 1 222 9491
Director of the Consumer Engagement area
Hugo Valdez
+52 (55) 4909 0836
IDEAS
22 Jul 2021

The first six months of Joe Biden: strategy, communicatio...

When Joe Biden became President of the United States six months ago, he entered the position amidst two major complicating factors, first being the COVID-19 pandemic. The sec...
13 Jul 2021

How to reverse or mitigate reputation crises in digital c...

In the third and penultimate article of the “Resilience” series, we address the challenge of tackling reputation crises in a high pressure, high transparency, and visceral n environment. of...
7 Jul 2021

Course in seduction for traditional banks

Spanish banks are emerging from the pandemic with the twin challenge of the digital transformation and ultra-low interest rates. Their traditional model ceased to be profitable a long time...
30 Jun 2021

How to Anticipate Reputational Risk in ESG

The world’s rapid progress in COVID-19 vaccination is leading to a strong recovery in both consumer and investor expectations (for example, the IBEX 35 index has risen 13% in...

We want to collaborate with you

Do you have a challenge?

Would you like to join our team?

Do you want us to speak at your next event?